Lab
Laboratory Corporation of America
Laboratory Corporation of America was paid $3.18M by Medicaid between Aug 2023 and Dec 2024, across 221 billing codes. Its largest line is 87591, Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe — 6.5% of everything it billed.
33Billing provider infoLABORATORY CORPORATION OF AMERICA
PORTLAND, OR 97213
PORTLAND, OR 97213
33aNPI1891473203assigned 07/06/2023
33bProvider typeClinical Medical Laboratory
28Total paid$3.18M
24GClaims450,452
24DCodes billed221
24AFirst – last monthAug 2023 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Oregon
Rank by total paid#10 of 46
Median peer was paid$50K
This provider vs. median64×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official WILLIAMS, KIMBERLY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2023 | 86,140 | $560K | |
| 2024incomplete | 364,312 | $2.62M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 6.5% | 9,546 | 9,122 | $206K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 6.5% | 9,521 | 9,096 | $206K |
| 36415 | Collection of venous blood by venipuncture | 6.1% | 56,243 | 48,369 | $195K |
| 80050 | General health panel | 4.6% | 5,256 | 4,912 | $147K |
| 80053 | Comprehensive metabolic panel | 4.2% | 29,725 | 27,219 | $134K |
| 84443 | Thyroid stimulating hormone (TSH) | 3.8% | 16,484 | 15,450 | $121K |
| 80061 | Lipid panel | 3.8% | 20,344 | 19,079 | $119K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 3.7% | 9,188 | 8,438 | $117K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 3.6% | 8,099 | 7,765 | $114K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 3.0% | 3,013 | 2,761 | $95K |
| 83036 | Hemoglobin; glycosylated (A1C) | 2.9% | 22,149 | 20,813 | $94K |
| 87510 | 2.7% | 7,221 | 6,855 | $87K |
209 more codes
| 87660 | 2.7% | 7,223 | $87K | |
| 87480 | 2.7% | 7,198 | $87K | |
| 82728 | 2.6% | 12,193 | $82K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 2.2% | 1,480 | $70K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.9% | 19,963 | $61K |
| 86480 | 1.7% | 1,844 | $55K | |
| 86803 | 1.6% | 6,028 | $49K | |
| 85027 | 1.4% | 14,830 | $45K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.4% | 10,874 | $44K |
| 86780 | 1.3% | 5,122 | $41K | |
| 84403 | 1.1% | 2,642 | $35K | |
| 84439 | 1.1% | 7,864 | $33K | |
| 82607 | 1.0% | 5,036 | $32K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 9,935 | $30K |
| 83970 | <1% | 2,038 | $26K | |
| 80081 | <1% | 488 | $23K | |
| 82670 | <1% | 1,562 | $22K | |
| 82274 | <1% | 2,347 | $22K | |
| 83550 | <1% | 5,488 | $21K | |
| 84153 | <1% | 2,341 | $19K | |
| 80074 | <1% | 713 | $18K | |
| 83880 | <1% | 1,331 | $17K | |
| 87186 | <1% | 4,306 | $17K | |
| 83540 | <1% | 5,928 | $17K | |
| 84402 | <1% | 1,276 | $16K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 200 | $16K |
| 82746 | <1% | 2,588 | $16K | |
| 87340 | <1% | 2,750 | $15K | |
| 83001 | <1% | 1,511 | $15K | |
| 87536 | <1% | 382 | $15K | |
| 87088 | <1% | 4,083 | $14K | |
| 86003 | <1% | 273 | $14K | |
| 87505 | <1% | 212 | $14K | |
| 87522 | Neg quan hep c or qual rna | <1% | 675 | $13K |
| 82570 | <1% | 6,270 | $13K | |
| 86235 | <1% | 285 | $12K | |
| 84702 | <1% | 1,333 | $12K | |
| 87070 | <1% | 2,365 | $12K | |
| 84481 | <1% | 1,417 | $11K | |
| 82043 | <1% | 4,744 | $11K | |
| 83921 | <1% | 1,249 | $11K | |
| 82784 | <1% | 1,599 | $10K | |
| 84146 | <1% | 929 | $10K | |
| 84270 | <1% | 842 | $9K | |
| 81001 | <1% | 7,126 | $9K | |
| 86762 | <1% | 974 | $9K | |
| 86140 | <1% | 3,521 | $8K | |
| 86364 | <1% | 1,284 | $8K | |
| 87077 | <1% | 2,404 | $8K | |
| 87338 | <1% | 1,035 | $8K | |
| 83002 | <1% | 777 | $8K | |
| 84144 | <1% | 740 | $7K | |
| 83735 | <1% | 2,971 | $7K | |
| 87529 | <1% | 395 | $7K | |
| 86704 | <1% | 1,139 | $7K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 321 | $7K |
| 80076 | <1% | 1,829 | $6K | |
| 87081 | <1% | 1,490 | $6K | |
| 86706 | <1% | 1,232 | $6K | |
| 86038 | <1% | 969 | $6K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 231 | $6K |
| 83690 | <1% | 1,656 | $6K | |
| 86376 | <1% | 795 | $6K | |
| 82627 | <1% | 501 | $6K | |
| 82533 | <1% | 693 | $5K | |
| 87517 | <1% | 286 | $5K | |
| 86850 | <1% | 813 | $5K | |
| 84425 | <1% | 499 | $5K | |
| 82105 | <1% | 752 | $4K | |
| 87641 | <1% | 285 | $4K | |
| 80069 | <1% | 2,012 | $4K | |
| 85652 | <1% | 3,434 | $4K | |
| 86800 | <1% | 549 | $4K | |
| 86592 | <1% | 1,592 | $4K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 47 | $4K |
| 86258 | <1% | 301 | $4K | |
| 86200 | <1% | 524 | $4K | |
| 82950 | <1% | 1,160 | $4K | |
| 86160 | <1% | 343 | $4K | |
| 83090 | <1% | 423 | $3K | |
| 85610 | <1% | 2,387 | $3K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 206 | $3K |
| 86141 | <1% | 574 | $3K | |
| 83525 | <1% | 547 | $3K | |
| 86787 | <1% | 418 | $3K | |
| 87209 | <1% | 363 | $3K | |
| 87493 | <1% | 177 | $3K | |
| 84550 | <1% | 1,620 | $3K | |
| 84156 | <1% | 1,940 | $3K | |
| 83521 | <1% | 126 | $3K | |
| 86431 | <1% | 874 | $3K | |
| 84165 | <1% | 597 | $2K | |
| 84100 | <1% | 1,300 | $2K | |
| 86696 | <1% | 212 | $2K | |
| 83721 | <1% | 485 | $2K | |
| 84480 | <1% | 331 | $2K | |
| 83993 | <1% | 206 | $2K | |
| 86665 | <1% | 130 | $2K | |
| 82785 | <1% | 263 | $2K | |
| 80175 | <1% | 370 | $2K | |
| 81374 | <1% | 61 | $2K | |
| 86361 | <1% | 150 | $2K | |
| 86225 | <1% | 280 | $2K | |
| 82951 | <1% | 220 | $2K | |
| 82550 | <1% | 625 | $2K | |
| 86708 | <1% | 311 | $2K | |
| 84590 | <1% | 303 | $2K | |
| 82024 | <1% | 85 | $2K | |
| 80164 | <1% | 441 | $2K | |
| 86900 | <1% | 827 | $2K | |
| 86901 | <1% | 825 | $2K | |
| 82565 | <1% | 759 | $2K | |
| 84630 | <1% | 283 | $2K | |
| 87177 | <1% | 364 | $1K | |
| 82977 | <1% | 439 | $1K | |
| 80177 | <1% | 301 | $1K | |
| 86695 | <1% | 206 | $1K | |
| 82248 | <1% | 703 | $1K | |
| 83520 | <1% | 163 | $1K | |
| 82525 | <1% | 234 | $1K | |
| 80197 | <1% | 400 | $1K | |
| 87075 | <1% | 241 | $1K | |
| 85730 | <1% | 454 | $1K | |
| 84305 | <1% | 92 | $1K | |
| 80178 | <1% | 416 | $1K | |
| 87329 | <1% | 180 | $1K | |
| 84154 | <1% | 151 | $1K | |
| 83498 | <1% | 54 | $1K | |
| 85379 | <1% | 210 | $1K | |
| 82247 | <1% | 448 | $968.28 | |
| 87205 | <1% | 443 | $926.07 | |
| 84155 | <1% | 674 | $902.54 | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 52 | $894.24 |
| 82040 | <1% | 399 | $863.94 | |
| 84446 | <1% | 106 | $854.35 | |
| 82310 | <1% | 445 | $841.91 | |
| 83655 | <1% | 111 | $788.36 | |
| 86381 | <1% | 27 | $788.26 | |
| 84207 | <1% | 59 | $767.22 | |
| 82166 | <1% | 31 | $747.98 | |
| 84436 | <1% | 269 | $731.97 | |
| 83516 | <1% | 113 | $730.78 | |
| 84450 | <1% | 319 | $728.86 | |
| 82150 | <1% | 214 | $723.19 | |
| 82947 | <1% | 393 | $691.14 | |
| 86593 | <1% | 297 | $651.23 | |
| 85049 | <1% | 235 | $641.29 | |
| 84484 | <1% | 110 | $634.47 | |
| 83615 | <1% | 261 | $628.50 | |
| 85048 | <1% | 400 | $619.81 | |
| 84075 | <1% | 270 | $609.76 | |
| 85018 | <1% | 508 | $596.76 | |
| 82952 | <1% | 213 | $535.96 | |
| 86015 | <1% | 94 | $531.70 | |
| 80235 | <1% | 50 | $512.46 | |
| 87101 | <1% | 115 | $480.94 | |
| 84460 | <1% | 188 | $465.52 | |
| 82390 | <1% | 80 | $452.77 | |
| 86664 | <1% | 56 | $427.92 | |
| 85041 | <1% | 236 | $426.75 | |
| 84520 | <1% | 226 | $405.60 | |
| 84478 | <1% | 194 | $398.52 | |
| G0307 | Complete (cbc), automated (hgb, hct, rbc, wbc; without platelet count) | <1% | 168 | $376.56 |
| 84432 | <1% | 53 | $360.14 | |
| 84703 | <1% | 84 | $357.74 | |
| 84132 | <1% | 185 | $349.99 | |
| 84134 | <1% | 62 | $347.14 | |
| 84295 | <1% | 179 | $346.69 | |
| 85045 | <1% | 189 | $345.36 | |
| 81015 | <1% | 229 | $339.24 | |
| 86705 | <1% | 51 | $305.20 | |
| 86709 | <1% | 52 | $294.49 | |
| 82435 | <1% | 155 | $293.99 | |
| 80159 | <1% | 45 | $265.55 | |
| 86359 | <1% | 16 | $237.48 | |
| 86735 | <1% | 43 | $237.48 | |
| 85014 | <1% | 230 | $236.16 | |
| 86334 | <1% | 31 | $234.36 | |
| 81003 | <1% | 260 | $234.30 | |
| 86360 | <1% | 14 | $230.23 | |
| 86644 | <1% | 29 | $227.18 | |
| 82172 | <1% | 19 | $209.04 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 419 | $207.70 |
| 86317 | <1% | 33 | $200.67 | |
| 84479 | <1% | 72 | $197.55 | |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | <1% | 43 | $178.92 |
| 82103 | <1% | 25 | $178.79 | |
| 82140 | <1% | 47 | $173.24 | |
| 81025 | <1% | 30 | $168.84 | |
| 82239 | <1% | 13 | $155.74 | |
| 84244 | <1% | 14 | $153.90 | |
| 86765 | <1% | 26 | $153.18 | |
| 86304 | <1% | 13 | $145.70 | |
| 87328 | <1% | 13 | $106.37 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 14 | $104.13 |
| 84681 | <1% | 13 | $101.99 | |
| 84466 | <1% | 14 | $89.30 | |
| 80156 | <1% | 14 | $85.52 | |
| 86663 | <1% | 14 | $82.62 | |
| 87206 | <1% | 19 | $79.22 | |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | <1% | 758 | $50.56 |
| 82397 | <1% | 12 | $49.40 | |
| 82330 | <1% | 13 | $47.90 | |
| G0475 | Hiv antigen/antibody, combination assay, screening | <1% | 310 | $46.57 |
| 83718 | <1% | 28 | $40.11 | |
| G0306 | Complete cbc, automated (hgb, hct, rbc, wbc, without platelet count) and automated wbc differential count | <1% | 15 | $38.08 |
| 86308 | <1% | 14 | $36.43 | |
| 83695 | <1% | 35 | $10.02 | |
| 99199 | Unlisted special service, procedure or report | 0% | 148 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWILLIAMS, KIMBERLY (VICE PRESIDENT)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.